IFNG and neoplasm: Importantly, while none of these patients displayed tumor regression, 5 had disease stabilization and the mean survival time for the subjects with higher frequencies of IFN-γ-producing PBMCs was tripled above those with low percentages of IFN-γ-producing PBMCs (29.3 versus 9.7 months) [117].